Cumberland Pharmaceuticals Inc.CPIXNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-23.48%
↓ 1485% below average
Average (39q)
1.70%
Historical baseline
Range
High:58.94%
Low:-39.10%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -23.48% |
| Q2 2025 | -7.48% |
| Q1 2025 | 12.24% |
| Q4 2024 | 14.86% |
| Q3 2024 | -7.75% |
| Q2 2024 | 15.90% |
| Q1 2024 | -9.15% |
| Q4 2023 | -7.27% |
| Q3 2023 | -7.37% |
| Q2 2023 | 18.04% |
| Q1 2023 | 1.11% |
| Q4 2022 | -20.06% |
| Q3 2022 | 10.82% |
| Q2 2022 | -7.84% |
| Q1 2022 | 34.32% |
| Q4 2021 | 3.06% |
| Q3 2021 | -10.85% |
| Q2 2021 | -14.06% |
| Q1 2021 | 2.69% |
| Q4 2020 | 10.93% |
| Q3 2020 | -3.62% |
| Q2 2020 | 15.21% |
| Q1 2020 | -39.10% |
| Q4 2019 | 31.88% |
| Q3 2019 | -10.44% |
| Q2 2019 | -2.71% |
| Q1 2019 | -11.82% |
| Q4 2018 | 58.94% |
| Q3 2018 | -16.44% |
| Q2 2018 | 18.35% |
| Q1 2018 | -26.28% |
| Q4 2017 | 4.04% |
| Q3 2017 | 29.19% |
| Q2 2017 | -10.06% |
| Q1 2017 | 6.11% |
| Q4 2016 | 3.29% |
| Q3 2016 | 18.57% |
| Q2 2016 | -4.17% |
| Q1 2016 | -3.73% |
| Q4 2015 | 1.93% |